ASP Isotopes Past Earnings Performance
Past criteria checks 0/6
ASP Isotopes's earnings have been declining at an average annual rate of -142.3%, while the Chemicals industry saw earnings growing at 9.7% annually.
Key information
-142.3%
Earnings growth rate
-66.5%
EPS growth rate
| Chemicals Industry Growth | 12.9% |
| Revenue growth rate | n/a |
| Return on equity | -168.8% |
| Net Margin | -1,178.1% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses Breakdown
How ASP Isotopes makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 2 | -27 | 21 | 1 |
| 31 Mar 24 | 1 | -20 | 18 | 1 |
| 31 Dec 23 | 0 | -16 | 15 | 1 |
| 30 Sep 23 | 0 | -13 | 13 | 1 |
| 30 Jun 23 | 0 | -11 | 10 | 1 |
| 31 Mar 23 | 0 | -8 | 7 | 1 |
| 31 Dec 22 | 0 | -5 | 4 | 1 |
Quality Earnings: ASPI is currently unprofitable.
Growing Profit Margin: ASPI is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if ASPI's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Unable to compare ASPI's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: ASPI is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-5.8%).
Return on Equity
High ROE: ASPI has a negative Return on Equity (-168.77%), as it is currently unprofitable.